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Organ transplant recipients (OTR)Warts from immunosuppressed organ transplant recipients (OTR) persist over years and may progress into
non-melanoma skin cancer. Human papillomaviruses (HPV) are considered the causal agents for the
development of such warts. We isolated the novel type HPV-117 from a persisting wart by rolling circle
ampliﬁcation. One hundred eighteen warts from immunocompetent patients (IC) and 49 warts from OTR
were analyzed by HPV-117 E6 type-speciﬁc PCR. As inferred from a phylogenetic analysis, the new type HPV-
117 belonged to alpha-PV species 2, including the most similar types HPV-10 and HPV-94. The general
prevalence of HPV-117 in warts was 2% in IC (2/118), and 12% in OTR (6/49). The high viral load in
dysplastic cells of a Verruca vulgaris was shown by in situ hybridization. Our results suggest an active role of
the novel type in the development of cutaneous warts of OTR.sequence of HPV-117 reported
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The complete genome of more than 100 human papillomavirus
(HPV) types has been characterized. HPV are classiﬁed into mucoso-
tropic (alpha-PV), cutaneotropic (beta-PV and gamma-PV) and
cutaneous, wart-associated types (species 2 and 4 of alpha-PV, mu-
PV and nu-PV) based on sequence similarities and clinical manifesta-
tions (de Villiers et al., 2004). Most HPV types have been initially
isolated and identiﬁed from genital/mucosal lesions, and PCR based
methods have identiﬁed a huge number of L1 gene fragments of
putatively novel cutaneous HPV types (Forslund et al., 1999, 2003). By
convention, a new PV type requires the isolation and characterization
of the entire genome (de Villiers et al., 2004), and viral genomic
fragments are not sufﬁcient to identify novel PV types.
In the general population, cutaneous warts are induced by alpha-
PV species 2 (HPV-3, -10, -28, -29, -77 and -94) and species 4 (HPV-2,
-27 and -57) as well as by mu-PV (HPV-1 and -63) and nu-PV (HPV-
41). HPV-2, -27 and -57 are the most prevalent types with this respect
(Rübben et al., 1993, 1997). From a phylogenetic perspective,
cutaneotropic alpha-PV species 2 and species 4 may derive from the
otherwise mucosotropic alpha-PV (Muñoz et al., 2003).A large number of organ transplant recipients (OTR) develop
warts and wart-like lesions during immunosuppression. Presence of
cutaneous warts increase with time after transplantation, and 39% of
560 OTR have developed Verrucae vulgares after 7 years (Bouwes
Bavinck et al., 2007). Cutaneous warts of OTR persist over years, are
often atypical and can show dysplasia. Moreover, they are
associated and co-localize with non-melanoma skin cancer, indicat-
ing that benign warts may progress into malignant skin cancer
during immunosuppression (Blessing et al., 1989; Euvrard et al.,
2003).
A more diverse range of cutaneotropic HPV types has been
reported in warts of OTR compared to immunocompetent patients
(IC) (Shamanin et al., 1994; Obalek et al., 1992; Harwood et al., 1999).
However, a subpopulation of warts from OTR does not appear infected
with known HPV types, although they show all characteristics of HPV-
induced skin alterations (Köhler et al., 2009). Here, we report the
complete genome of a novel, wart-associated HPV type isolated from a
persisting wart of an OTR, who has been previously considered HPV
negative.We examine the histological localization of the novel type by
in situ hybridization and the prevalence in warts of IC (n=118) and of
OTR (n=49) using type-speciﬁc PCR.
Results and discussion
The novel type had the principle genome organization found in the
majority of mucosotropic alpha-PV types, consisting of the four large
genes E1, E2, L2 and L1 and the three smaller genes E6, E7 and E5
(García-Vallvé et al., 2005). The complete genome of HPV-117
comprised 7895 bp, and the L1 nt sequence showed the highest
similarity of 87.5% with both HPV-10 and HPV-94, as inferred from a
Fig. 1. HPV-117 belongs to alpha-PV species 2. ML tree of PV comprising a
representative set of 24 alpha-PV, as inferred from a combined E1–E2–L2–L1 amino
acid (aa) analysis (1553 parsimony-informative aa positions). HPV-117 is highlighted
by bold lettering. PV character traits are colored green (human alpha-PV low-risk
types), red (human alpha-PV high-risk types), blue (non-human alpha-PV types) and
ochre (wart-associated alpha-PV types), respectively. Branch lengths are drawn to scale
(outgroup types are in black). Scale bar, number of aa substitutions per site. Numbers
on branches are bootstrap support values to clusters of the right of them (above: ML
criterion; below: Bayesian posterior probabilities; values under 50 and 0.90 are not
shown). HPV types lacking the pRb-binding motif (see Fig. 2) are highlighted by the
shaded box.
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dateien/KoehlerAlpha.xls). Primary sequence analysis, including
position and length of the ORF, are summarized in Table 1. The non-
coding region was located upstream of the E6 gene, and downstream
of the L1 gene, and comprised 675 nt. Potential polyadenylation
signals in this region were present for the early genes (nt 4421) and
the late genes (nt 7447).
The alignment for the multi-gene phylogenetic analysis was 2421
aa positions in length, and 1553 of these sites (64%) were parsimony-
informative (55.5 per terminal taxon). Fig. 1 shows the best-scoring
ML-tree (−ln=67264.44), with the statistical support values for the
two phylogenetic approaches used. alpha-PV were monophyletic,
irrespectively whether the data were analyzed under the likelihood
criterion (bootstrap support value from ML analysis: 100 LBS) or the
Bayesian approach (Bayesian posterior probability: 1.00 BPP). Low-
risk human alpha-PV types were a paraphyletic assemblage, from
which PV clades with other character traits derived. Such clades
included non-human PV that were polyphyletic, as well as high-risk
human alpha-PV types. Cutaneous wart-associated alpha-PV types
constituted two monophyletic groups (alpha-PV species 2 and 4) that
were only distantly related to each other. The new type HPV-117
belonged to alpha-PV species 2 (100 LBS, 1.00 BPP), but the closest
relative could not be determined unequivocally (either HPV-10 or
HPV-94). The results support the principle correspondence between
phylogenetic relationships and viral properties within mucosotropic
alpha-PV (Muñoz et al., 2003).
The ability of PV to induce proliferation of the infected cells has
been attributed mainly to the two viral oncogenes E6 and E7. The
corresponding oncoproteins bind host cellular proteins, with the
tumor suppressors, p53 and retinoblastoma protein (pRb), as major
targets (Münger et al., 2004). The E7 ORF of the vast majority of PV
contains the conserved pRb-binding core sequence LxCxE (Boulet
et al., 2007). However, this motif is absent from a subset of alpha-
PV species 2 including HPV-117 (Figs 1 and 2). The lack of a pRb-
binding motif is rare among PV and is only known from ruminant
delta-PV and epsilon-PV as well as from a few solitary other types.
Moreover, this character trait may correlate with speciﬁc pathol-
ogies (Narechania et al., 2004).
A number of zinc-binding domains is characteristic for the two
oncogenes E6 and E7 (Nomine et al., 2006; Liu et al., 2006). The E7 ORF
of HPV-117 exhibited one regular zinc-binding domain at aa position
50 [CxxC(x)29CxxC] (Fig. 2). However, the E6 ORF contained only one
of two regular zinc-binding domains [CxxC(x)29CxxC] (data not
shown). The ﬁrst started at aa position 29 and was separated by 36 aa
from the mutated second motif. The loss of the second zinc-ﬁnger
domain at nt position 417 was due to a missense mutation (A instead
of G), resulting in a replacement of tyrosin for cystein at aa position
105 (C105Y). This mutation was also found in sequences ampliﬁed
from 8 warts that were infected with HPV-117 using type-speciﬁc
primers. Thus, the loss of the second zinc-ﬁnger domain is not due to
experimental artefacts, but is biologically present in the novel type
HPV-117.Table 1
Primary sequence analysis of the HPV-117 genes and sequence similarity to the closely rela
Gene(s) Genome length E6 E7




Number of amino acids [aa] – 147 87
Molecular weight [kDa]b – 19.8 11.7
Sequence similarity
[percentage nt (percentage aa)]
HPV-10 86 (82) 91 (86)
HPV-94 86 (79) 93 (88)
Putative E5 ORF (nt 4152–4295).
a Putative E4 without ATG.
b Average molecular weight of about 135 Da.As a component of alpha-PV species 2, HPV-117 had a putative E5
ORF (nt 4152-4295) between the genes E2 and L2, as it has been also
described for the closely related type HPV-94 (de Villiers and Gunst,
2009). In alpha-PV, four types of E5 proteins have been identiﬁed,
with different biochemical properties and corresponding to phyloge-
netic groups (Bravo and Alonso, 2004). The E5beta-protein is present
in alpha-PV species 2, 3, 4, 14 and 15 including HPV-117 and has a
distinct hydrophobic proﬁle over its aa sequence.
Overall, little is known about the causal HPV types in warts of
immunosuppressed OTR due to the small number of studies analyzing
the presence of HPV in warts of this cohort. Cutaneous (beta-, and
gamma-PV) and wart-associated HPV types (species A2 and A4 of
alpha-PV, mu-, and nu-PV) were found in 76% (37/49) of OTR by PCR
based methods. HPV-117 was detected in warts from 2% (2/118) of
the general population and from 12% (6/49) of OTR. Of these HPV-117
positive warts, multiple infections with additional cutaneous HPVted types HPV-10 and HPV-94.











679 382 110 463 533
91.7 51.6 14.9 62.5 72.0
90 (92) 87 (83) 87 (80) 86 (89) 88 (92)
89 (91) 88 (84) 87 (79) 84 (87) 88 (91)
Fig. 2. A subset of alpha-PV species 2 do not exhibit a pRb-binding motif in the E7 open reading frame (ORF). Alignment of the E7 ORF of different PV types. Note that some alpha-PV
species 2, constituting a monophyletic group (Fig. 1) and including the novel type HPV-117, lack the pRb-binding motif LxCxE at alignment positions 28–32 (indicated by a yellow
box). Additionally, the dimeric C-terminal zinc-binding domain [CxxC(x)29CxxC] constraining the protein's fold is indicated by yellow boxes.
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infections were present in 2/6 warts of OTR. Moreover, the novel type
was present in the nucleus of dysplastic keratinocytes of the wart
shown by in situ hybridization (Fig. 3). The high viral load, and the
presence in the lesion, suggests that HPV-117 is the etiological agent
of this cutaneous wart.
In conclusion, HPV-117 belongs to alpha-PV species 2, whose types
induce cutaneous warts and share viral properties. The new type is
localized in dysplastic keratinocytes and is a widely distributed type
among OTR. To further determine the pathogenicity of the novel type,
functional analyses of viral genes in human cells and human primary
keratinocytes, and their interactions with UV-radiation, are required.
Our studymay contribute to a better understanding how benignwarts
may progress into malignant skin cancer during immunosuppression.
Materials and methods
Patients
The Verruca vulgaris from an immunosuppressed renal transplant
recipient (42-year-old male) persisted over 24 months. The wart was
removed fromtheback of the righthandbydeep curettage to thedermis
at the time of surgery. The biopsy was divided into two halves, one was
snap frozen in liquidnitrogen and stored at−80 °C, and the other half of
the biopsy was ﬁxed in formalin and embedded in parafﬁn. Parafﬁn
embedded sections of the Verruca vulgaris were used for histological
evaluation and in situ hybridization. Moreover, we examined 167
parafﬁnembeddedwarts (conﬁrmedbyhistology), including118 ICand
49 immunosuppressed OTR. This studywas approved by the local ethics
committee at the Charité, UniversityHospital, Berlin, Germany (number
Si. 248) and was conducted according to the Declaration of Helsinki.
HPV detection and isolation of new types
DNAwas isolated from tissue using QIAamp DNAMini Kit (Qiagen,
Hilden, Germany). HPV detection of cutaneous types (beta-, andgamma-PV) and wart-associated types (species A2 and A4 of alpha-PV,
mu-, and nu-PV) was performed by PCR based methods as previously
described (Köhler et al., 2009). To obtain novel HPV type(s), rolling
circle ampliﬁcation (RCA) of the episomal viral DNA was performed
with a TempliPhi 500 Ampliﬁcation kit (Amersham Biosciences,
Munich, Germany).We followedanoptimized protocol using additional
nucleotides to obtain higher folds of ampliﬁcation as previously
described (Schulz et al., 2009). Puriﬁed DNA of the complete HPV
genome was cloned into pUC19 (Invitrogen, Karlsruhe, Germany) at
the BamHI restriction site, and sequencing was performed by primer
walking (GENterprise, Mainz, Germany). The clone, and the
corresponding complete genome sequence, was submitted to the
International Reference Centre for Papillomaviruses at the German
Cancer Research Centre, Heidelberg, Germany. The novel type was
designated HPV-117 (GenBank accession no. GQ246950).
Protein prediction and phylogenetic analyses
Open reading frames (ORF) were predicted using ‘ORFinder’
(http://www.ncbi.nlm.nih.gov/gorf/gorf.html). They were con-
ﬁrmed by the manual alignment of nucleotide (nt) and amino acid
(aa) sequences to homologous regions of most similar PV types in
‘BioEdit’ (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Pri-
mary sequence analysis of the predicted proteins was performed
with ‘ProtParam’ (www.expasy.ch/tools/protparam.html), ‘Prosite’
(Hulo et al., 2008) and ‘PSORT II’ ( http://psort.ims.u-tokyo.ac.jp/
form.html).
The taxon sample for phylogenetic analyses covered the currently
known diversity of wart-associated PV types, embedded in a
representative set of alpha-PV, and comprised 28 complete PV
sequences (including HPV-117 and 4 outgroup taxa; see Supplemen-
tary Table S1). After exclusion of the highly divergent E4 gene region,
an aa alignment (comprising the genes E1–E2–L2–L1) was constituted
using ‘MAFFT’ (v6.523; (Katoh et al., 2005); http://align.bmr.kyushu-
u.ac.jp/mafft/software/). The ﬁnal matrix is available at http://htcc.
pt-dlr.de/dateien/KoehlerAlpha.nex. A sequence identity matrix of a
Fig. 3. HPV-117 DNA detection in Verruca vulgaris by in situ hybridization. Three
consecutive sections of a 24-month persisting wart from an immunosuppressed renal
transplant recipient (42-year-old male). (A) Negative control, the section was stained
with cutaneotropic HPV-8. (B) The section was stained with the type-speciﬁc genome
of HPV-117 that was isolated from this wart. HPV-117 DNA (red spots marked by
arrows) was only present in the nucleus of dysplastic keratinocytes. (C) Staining with
hematoxylin and eosin. Histology showed characteristic features of Verruca vulgaris:
Vacuolar transformation and parakeratosis was observed in the thickened horny layer
as well as acanthosis in the spinous and granular layer of the epidermis (scale
bar=50 μm).
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‘BioEdit’ (v7.0.0; (Hall, 1999). Phylogenetic analyses were conducted
using ‘RAxML’ (Stamatakis, 2006; Stamatakis et al., 2008); http://
www.phylo.org/portal/Home.do) and ‘MrBayes’ v3.1.2 (Huelsenbeck
and Ronquist, 2001), applying the rtREV substitution model (Dimmic
et al., 2002) as previously described (Gottschling et al., 2007).
Bayesian calculations were carried out by using the resources of the
Computational Biology Service Unit from Cornell University, which is
partially funded by Microsoft Corporation. We ran two independent
analyses of 4 (1 cold and 3 heated) mcmc chains with 6,000,000
cycles, sampled every 1000th cycle, with an appropriate burn-in
(10%).
In situ hybridization
In situ hybridization of parafﬁn-embedded tissue sections (5 μm)
was performed as previously described (Nafz et al., 2007). Brieﬂy, the
tissue was digested with proteinase K and pre-hybridized. Hybrid-
ization was conducted with pre-hybridization buffer, supplemented
with 500 ng biotinylated HPV genome DNA (HPV-117 or HPV-8, both
cloned in pUC19) using a biotin-nick translation kit (Roche,
Mannheim, Germany). After the washing steps, slides were incubated
with a streptavidin-horseradish peroxidase (HRP) conjugate, and the
signal was ampliﬁed with the biotin derivative and ampliﬁcation
reagent biotinyltyramid (Perkin Elmer, Norwalk, CT). Red precipitate
of 3-amino-9-ethylcarbazol chromogen substrate (AEC; Dako, Ham-
burg, Germany) activated by HRP represent HPV DNA, and nuclei
were counterstained with hematoxylin.
Type-speciﬁc PCR
To determine the prevalence of the novel type, we analyzed
cutaneous warts of IC and OTR. HPV-117 E6 type-speciﬁc PCR was
performed with forward and reverse primers (5′-GCCTCAAACATTGG-
GAACAT-3′ and 5′-CAGTCGTCGTCGTTCGTTAC-3′). Each ampliﬁcation
mix contained in aﬁnal volumeof 50 μl 0.5μmol L−1of eachgene-speciﬁc
primer, 0.2 mmol L−1 dNTPs, 1.5 mmol L−1 MgCl2 in 1× PCR buffer
(Qiagen), 0.3 units of Taq polymerase (Qiagen) and 1 μL of templateDNA.
The corresponding PCR was performed under the following conditions:
initial denaturation at 94 °C for 4 min; 40 cycles comprising the steps
94 °C for 45 s, 60 °C for 45 s, 72 °C for 45 s, andﬁnal elongation at 72 °C for
4 min. The PCR products with a size of 152 bp were separated by
electrophoresis in 2% agarose gel, and the isolated products were
sequenced. The sequences were aligned using the software program
CodonCode Aligner (version 3.0, CodonCode Corporation, Dedham, USA)
and were compared to the prototype sequence of HPV-117.
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